Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 9:14:1463088.
doi: 10.3389/fonc.2024.1463088. eCollection 2024.

From defense to offense: antimicrobial peptides as promising therapeutics for cancer

Affiliations
Review

From defense to offense: antimicrobial peptides as promising therapeutics for cancer

Hadi Zare-Zardini et al. Front Oncol. .

Abstract

Antimicrobial peptides (AMPs), naturally occurring components of innate immunity, are emerging as a promising new class of anticancer agents. This review explores the potential of AMPs as a novel class of anticancer agents. AMPs, naturally occurring peptides with broad-spectrum antimicrobial activity, exhibit several characteristics that make them attractive candidates for cancer therapy, including selectivity for cancer cells, broad-spectrum activity, and immunomodulatory effects. Analysis of a dataset of AMPs with anticancer activity reveals that their effectiveness is influenced by various structural properties, including net charge, length, Boman index, and hydrophobicity. These properties contribute to their ability to target and disrupt cancer cell membranes, interfere with intracellular processes, and modulate the immune response. The review highlights the promising potential of AMPs as a new frontier in cancer treatment, offering hope for more effective and less toxic therapies. AMPs demonstrate promising potential in cancer therapy through multiple mechanisms, including direct cytotoxicity, immune response modulation, and targeting of the tumor microenvironment, as evidenced by extensive preclinical studies in animal models showing tumor regression, metastasis inhibition, and improved survival rates. AMPs show significant potential as cancer therapeutics through their direct cytotoxicity, immune response modulation, and tumor microenvironment targeting, with promising results from preclinical studies and early-phase clinical trials. Future research should focus on optimizing AMP properties, developing novel delivery strategies, and exploring synergistic combination therapies to fully realize their potential as effective cancer treatments, while addressing challenges related to stability, delivery, and potential toxicity.

Keywords: antimicrobial peptides; cancer therapy; cytotoxicity; immunomodulation; tumor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The sources of antimicrobial peptides with anticancer effects.
Figure 2
Figure 2
Physicochemical properties based upon sequence information of reported antimicrobial peptides with anticancer activity.

Similar articles

Cited by

References

    1. Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. (2022) 95:20211033. doi: 10.1259/bjr.20211033 - DOI - PMC - PubMed
    1. Saberian E, Jenča A, Petrášová A, Zare-Zardini H, Ebrahimifar M. Application of scaffold-based drug delivery in oral cancer treatment: A novel approach. Pharmaceutics. (2024) 16:802. doi: 10.3390/pharmaceutics16060802 - DOI - PMC - PubMed
    1. Yazdi AM, Mazidi M, Tarzi MG, Zardini HZ. Investigating the toxicity of germ of date seed on normal and cancerous cell line and P53 gene expression. Acad J Health Sciences: Medicina Balear. (2023) 38:62–5.
    1. Ngoma TA, Ngoma M. Global burden of cancer. In: Kickbusch I, Ganten D, Moeti M, editors. Handbook of Global Health. Springer International Publishing, Cham: (2021). p. 459–94.
    1. Jafari Nodoshan A, Zare-Zardini H, Mosavvan M, Hashemi A, Jenabzadeh A. Analysis of pulmonary complications in pediatric acute lymphocytic leukemia patients following three years of chemotherapy treatment: A cross-sectional study. Iranian J Pediatr Hematol Oncol. (2024) 14:180–7. doi: 10.18502/ijpho.v14i3.15986 - DOI

LinkOut - more resources